Zepbound (Tirzepatide): A once-weekly dual agonist (GLP-1/GIP receptor agonist) injection FDA-approved for the treatment of obesity and obstructive Sleep Apnea
CrossRef Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study Hala Zakaria, Hadoun Jabri, Sheikha Alshehhi, Milena Caccelli, Joelle Debs, Yousef Said, Joudy Kattan, Noah Almarzooqi, Ali Hashemi, Ihsan Almarzooqi Interactive Journal of Medical Research.2025
The cost of GLP-1 medications varies based on insurance coverage and individual plan benefits
TB-500 studied for tissue repair, blood flow, and reduced inflammation
It belongs to a class of medications known as GLP-1 receptor agonists, which mimic the effects of a natural hormone, glucagon-like peptide-1 (GLP-1)
At 10 mg/mL, where a 0.25 mg dose is 2.5 units, a 30-unit syringe lets you draw to the fifth tick mark with confidence